Review Article
Gestational Trophoblastic Disease: A Multimodality Imaging Approach with Impact on Diagnosis and Management
Table 1
(a) FIGO 2000 classification for GTN-staging system. (b) FIGO 2000 classification for GTN-risk scoring system.
(a) |
| Stage I | Disease confined to the uterus. | Stage II | GTN extends outside the uterus but is limited to the genital structures (adnexa, vagina, and broad ligament). | Stage III | GTN extends to the lungs, with or without known genital tract involvement. | Stage IV | All other metastatic sites. |
|
|
Source: FIGO Oncology Committee (2003) [10].
|
(b) |
| Score | 0 | 1 | 2 | 4 | Age (years) | <40 | ≥40 | — | — | Antecedent pregnancy | Mole | Abortion | Term | — | Interval months from index pregnancy | <4 | 4–<7 | 7–<13 | ≥13 | Pretreatment serum -hCG (iu/mL) | <103 | 103<104 | 104<105 | ≥105 | Largest tumor size (cm) (including uterus) | <3 | 3–<5 | ≥5 | — | Site of metastases | Lung | Spleen, kidney | Gastrointestinal | Liver, brain | Number of metastases | — | 1–4 | 5–8 | >8 | Previous failed chemotherapy | — | — | Single drug | Two or more drugs |
|
|
Source: FIGO Oncology Committee (2003) [10].
|